drugset / Trial / NCT00144196

12 Week Efficacy of Tiotropium Versus Placebo in Patients With Mild COPD According to Swedish Guidelines (SPIRIMILD)

NCT00144196

Phase 4 Completed 224 enrolled Boehringer Ingelheim
RandomizedParallel-groupDouble-blindTreatment

Summary

To show that treatment with tiotropium inhalation capsules (18 μg q.d.) via HandiHaler® improves lung function in patients with mild COPD according to Swedish guidelines.

Timeline

Start
2004-03-11
Primary completion
2005-07-25
Completion
2005-07-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Tiotropium Other / unclassified 18 ug Inhaled